Table 3: Risk factors for preeclampsia and
markers of severity of preeclampsia compared between non-users and
methamphetamine users. Values are mean ± standard deviation or n (%).
a AST=aspartate aminotransferase, bALT=alanine transaminase
|
|
Non-Users |
Meth-Users |
|
|
N |
166 |
34 |
p |
|
Advanced maternal age |
29 (18) |
12 (35) |
0.033 |
|
Nulliparous |
75 (45) |
10 (29) |
0.127 |
|
Preterm Birth |
53 (32) |
15 (44) |
0.122 |
|
Pre-existing diabetes |
3 (4) |
1 (5) |
0.560 |
|
Chronic hypertension |
21 (21) |
7 (33) |
0.255 |
|
Previous pregnancy with preeclampsia |
6 (7) |
5 (26) |
0.027 |
|
Smoker |
10 (6) |
9 (27) |
0.001 |
|
Other drugs |
|
|
|
|
Cannaboids |
6 (3.6) |
5 (14.7) |
0.018 |
|
Alcohol |
2 (1.2) |
1 (2.9) |
|
|
Opiates |
6 (3.6) |
0 |
|
|
Heroine |
2 (1.2) |
0 |
|
|
Body-Mass-Index (kg/m2) |
34.7 ± 7.1 |
34.4 ± 7.5 |
0.853 |
|
Obese (Body-Mass-Index > 30kg/m2) |
73 (75) |
14 (75) |
1 |
|
Peak systolic blood pressure |
159 ± 14 |
168 ± 23 |
0.004 |
|
Peak diastolic blood pressure |
96 ± 10 |
100 ± 14 |
0.030 |
|
Peak ASTa (mg/dL) |
33 ± 55 |
53 ± 147 |
0.190 |
|
Peak ALTb (mg/dL) |
27 ± 47 |
47 ± 130 |
0.150 |
|
Platelet nadir (x100,000) |
193 ± 57 |
230 ± 74 |
0.002 |
|
Composite Morbidity |
2.4 ± 1.3 |
2.5 ± 1.0 |
0.563 |